NCT05735730View on ClinicalTrials.gov

Can the Risk for AMD be Modulated?

NAActive, not recruitingINTERVENTIONAL
Enrollment

1,800

Participants

Timeline

Start Date

June 26, 2023

Primary Completion Date

February 6, 2025

Study Completion Date

January 12, 2028

Conditions
Age-Related Macular Degeneration (ARMD)
Interventions
OTHER

Blood draw

The study intervention consists of a blood draw for genetic analysis.

Trial Locations (1)

3000-548

AIBILI-CEC (AIBILI- Clinical Trials Centre), Coimbra

All Listed Sponsors
lead

Association for Innovation and Biomedical Research on Light and Image

OTHER